RecruitingElbow Joint DestructionPost-traumatic LesionsAnkylosed Joints
Clinical Outcomes Study of the Nexel Total Elbow
Eligible age
18+ yrs
Accepts
All genders
Locations
4 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
Sponsor: Zimmer Biomet
You may qualify if…
- ✓ Patient is 18 years of age or older.
- ✓ Patient must have signed Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent.
- ✓ Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the following:
- ✓ Elbow joint destruction which significantly compromises daily living activities
- ✓ Post-traumatic lesions or bone loss contributing to elbow instability
- ✓ Ankylosed joints, especially cases of bilateral ankylosis from causes other than active sepsis
- ✓ Advanced rheumatoid arthritis, post-traumatic, or degenerative arthritis with incapacitating pain
- ✓ Instability or loss of motion when the degree of joint or soft tissue damage precludes reliable osteosynthesis
You may not qualify if…
- ✕ Patient has a currently active or history of repeated local infection at the surgical site.
- ✕ Patient has a current major infection distant from the operative site.
- ✕ Patient has a history of prior sepsis.
- ✕ Patient suffers from paralysis or dysfunctional neuropathy at the elbow joint.
- ✕ Patient has significant ipsilateral hand dysfunction.
- ✕ Patient has excessive scarring near the surgical site, which could prevent adequate soft tissue coverage.
- ✕ Patient participates in daily activities that may cause significant stress to an implanted device such as heavy labor, torsional stress, and/or competitive sports.
- ✕ Patient is a prisoner.
Where it's recruiting
Source: ClinicalTrials.gov · NCT02469662 · last updated 2025-10-29